Oslo, Norway, 14 November 2025 – Omda AS (Euronext Growth Oslo: OMDA) today announced its financial results for the third quarter of 2025.
Reported revenue growth for the quarter was 14% compared with the same period last year, with an EBITDA margin of 30%.
CEO Sverre Flatby commented: “Omda’s strong first half was followed by a record third quarter result.”
The company has previously guided annual revenues of 460–485 MNOK for 2025. With year-to-date revenues of 360 MNOK, Omda now expects that full-year revenue to end toward the upper end of the guided range. The EBITDA margin guidance of 23–27% for the year is maintained.
“This quarter further strengthens the foundation for our public guidance for both 2025 and 2026,” Flatby added. Omda has previously communicated guidance for 2026 of 500–525 MNOK in revenue and an expected EBITDA margin of 28–32%.
“Our profitable, market-leading portfolio of niche solutions within specialised healthcare and emergency services has been built through a series of acquisitions. Our current M&A pipeline indicates that 10–20% inorganic growth will be added on top of the guided 2026 revenues,” Flatby concluded.
Highlights from the report:
- EBITDA margin of 30%
- Reported growth of 14% vs. Q3-24
- Organic growth of 7% vs. Q3-24
- ARR up 15% vs. Q3-24
- Working capital 8 percentage points better than in Q3-24
For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@omda.com
About Omda
Omda is the leading provider of niche software for specialised healthcare
and emergency services in the Nordics with a growing presence in Europe,
North America and the Pacific region. The company has more than 750
contracts in 25 countries and employs approximately 260 dedicated
specialists. Our highly specialised healthcare solutions empower medical
professionals and emergency responders, enabling them to know more and
work smarter. With a focus on user-centric design, value-driven development
and close working relationships with customers, Omda delivers solutions
that enhance patient safety and improve healthcare outcomes.
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH
